Delivery Order SPE2DE21D7010-SPE2D626F20K5

Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $1,956.60 delivery order (Contract No. 4570300075) by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, for the supply of MAXCESS spinal surgical products. The contract utilizes a fixed-price pricing structure with economic price adjustment mechanisms and carries no set-aside designation, reflecting successful competition in open market procurement. Performance is scheduled for completion by January 6, 2026, at Nuvasive's San Diego, California facility. This delivery order is issued against the company's existing relationship with the DLA Medical Supply Chain, through which Nuvasive has become a critical supplier of advanced spinal fusion devices, implants, surgical instruments, and bone graft materials to the Department of Defense and Department of Veterans Affairs healthcare systems.

This award supports the federal military and veteran healthcare enterprise's surgical capabilities by providing specialized spinal technologies required for complex orthopedic and neurological procedures. Nuvasive operates under its parent company's $8 million Blanket Purchase Agreement with the Defense Health Agency (effective through March 2027), structured as an Indefinite Delivery/Indefinite Quantity contract vehicle that streamlines procurement of the company's comprehensive spinal medical device portfolio across DoD and VA medical facilities nationwide. The DLA Medical Supply Chain procures medical supplies and equipment to support Department of Defense and Department of Veterans Affairs healthcare operations, and Nuvasive's sustained contract activity demonstrates its established capability as a qualified vendor for mission-critical orthopedic and neurosurgical technologies supporting operational readiness and medical care delivery.